NFKB1 and neoplasm: It has been also reported that administration of an NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), significantly decreased the serum IL-6 level in tumor-bearing cachectic mice, resulting in the improvement of both the epididymal fat weight and serum triglyceride level [30].